Dignicap

Allure Magazine: Cap that can help prevent chemo hair loss now available

April 11, 2016
 

DigniCap is a new device promising to help cancer patients keep their hair during chemotherapy. The Cancer Therapy & Research Center was the first to use the device simultaneously with chemotherapy.



Time Warner Cable News: How to Avoid the Guilt of Overeating During Fiesta

April 10, 2016
 

If you live in San Antonio long enough you know by now which foods to eat in moderation during Fiesta, or avoid. In this edition of “Health and Medicine,” John Garcia has more on how to avoid packing on those unwanted pounds. Watch the full story at Time Warner Cable News


Business Wire: Gilead Announces Multiple Scientific Presentations Demonstrating Broad Utility of Sofosbuvir-Based Hepatitis C Therapies

April 8, 2016
 

Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from several Phase 2 and Phase 3 studies evaluating its two investigational, pangenotypic, fixed-dose combination therapies for the treatment of chronic hepatitis C virus (HCV) infection, as well as new data highlighting the potential use of Harvoni® (ledipasvir/sofosbuvir) in adolescents aged 12 to 17. Data were presented […]


Science Daily: Additional benefits of type 2 diabetes treatment found for non-alcoholic fatty liver disease patients

April 8, 2016
 

Scientists have uncovered a way to improve liver metabolism for those with non-alcoholic fatty liver disease by using an acute dose of an existing diabetes treatment. Read the full story at Science Daily


Healio: MAGELLAN-I: Novel regimen yields strong results in experienced patients with RAVs

April 8, 2016
 

Fred Poordad, M.D., of the Health Science Center, presents new findings on cirrhosis at the International Liver Congress in Barcelona.


MedPage Today: Combo Tx Offers ‘Salvage’ in Tough-to-Treat HCV

April 8, 2016
 

An investigational drug combination offers renewed hope of a cure for chronic hepatitis C (HCV) patients who have tried and failed therapy with the new direct-acting antiviral agents, a researcher said here. Read the full story at MedPage Today